Zai Lab Limited American Depositary Shares Share Price
NASDAQ: ZLAB | Large CapZai Lab Limited American Depositary Shares Stock Performance
Open $21.72 | Prev. Close $20.88 | Circuit Range N/A |
Day Range $21.71 - $24.05 | Year Range $15.97 - $36.72 | Volume 78,164 |
Average Traded $23.32 |
Zai Lab Limited American Depositary Shares Share Price Today
As of 10 August 2026, Zai Lab Limited American Depositary Shares's share price is $23.32. The stock opened at $21.72, compared to its previous close of $20.88. During today's trading session, Zai Lab Limited American Depositary Shares's share price traded between $21.71 and $24.05, with an average price of $22.88. Over the past 52 weeks, the stock has recorded a high of $36.72 and a low of $15.97. In terms of performance, Zai Lab Limited American Depositary Shares's share price has risen by 21.18% over the last six months and is down 29.63% on a year-on-year basis.
Zai Lab Limited American Depositary Shares Share Price Chart
Zai Lab Limited American Depositary Shares Stock Fundamentals & Key Indicators
Market Cap $25.54B | PE Ratio (TTM) -145.72 | Dividend Yield N/A |
EPS (TTM) $-0.16 | Revenue (TTM) $457.18M | Return On Equity (TTM) -24.53% |
Profit Margin -38.40% | Debt to Equity 0.58 | Quarterly Earnings Growth YoY 13.70% |
Zai Lab Limited American Depositary Shares Quarterly Profit & Loss
All figures in USD
Zai Lab Limited American Depositary Shares Annual Profit & Loss
All figures in USD
About Zai Lab Limited American Depositary Shares
Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; NUZYRA for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections; Optune for glioblastoma multiforme; Qinlock for gastrointestinal stromal tumors; Xacduro for treating hospital-acquired and ventilator-associated bacterial pneumonia caused by a cinetobacter baumannii-calcoaceticus complex; and Augtyro for the treatment of ROS proto-oncogene 1 and non-small cell lung cancer. The company's oncology pipeline includes bemarituzumab, tumor treating fields, tisotumab vedotin, and repotrectinib; and immunology, neuroscience, and infectious disease pipeline comprises efgartigimod and xanomeline and trospium chloride. Zai Lab Limited has license and collaboration agreements with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure Ltd. to develop and commercialize Tumor Treating Fields; Deciphera Pharmaceuticals, LLC to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx BV to develop and commercialize efgartigimod; Bristol-Myers Squibb Company to develop and commercialize tisotumab vedotin and repotrectinib; Amgen Inc. to develop and commercialize bemarituzumab; Innoviva, Inc. to develop and commercialize Sulbactam-Durlobactam; and Karuna Therapeutics, Inc. to develop and commercialize Xanomeline and trospium chloride, as well as strategic collaboration with Pfizer Inc. for sulbactam and durlobactam. The company was incorporated in 2013 and is based in Shanghai, China.
Zai Lab Limited American Depositary Shares Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $18.27 | $23.32 | +27.65% |
Jul 2026 | $19.01 | $18.27 | -3.92% |
Jun 2026 | $17.56 | $19.01 | +7.40% |
May 2026 | $21.52 | $17.70 | -18.30% |
Apr 2026 | $19.95 | $21.66 | +15.21% |
Mar 2026 | $18.27 | $18.80 | -2.26% |
Feb 2026 | $16.32 | $19.24 | +15.87% |
Jan 2026 | $17.42 | $16.61 | -5.81% |
Dec 2025 | $20.11 | $17.63 | -13.75% |
Nov 2025 | $26.95 | $20.44 | -21.79% |
Oct 2025 | $34.00 | $26.14 | -22.87% |
Sep 2025 | $32.91 | $33.88 | +2.28% |
ZLAB Share Price FAQs
What is Zai Lab Limited American Depositary Shares share price today?
What is the 52 week high and 52 week low of Zai Lab Limited American Depositary Shares stock?
What is ZLAB's market capitalisation today?
What is ZLAB's net income for the last quarter?
What is the 5 year returns of ZLAB?
What is the high & low stock price of ZLAB today?
Can I buy ZLAB shares in India?